Niemi T T, Kuitunen A H
Department of Anaesthesiology and Intensive Care Medicine, Helsinki University Central Hospital, Helsinki, Finland.
Acta Anaesthesiol Scand. 2005 Mar;49(3):373-8. doi: 10.1111/j.1399-6576.2005.00619.x.
Hydroxyethyl starch (HES) solutions impair haemostatic mechanisms. The impact of the degree of substitution (DS) of a HES solution on thromboelastometry tracings is unclear. Therefore we tested the hypothesis of whether the DS has an effect on the haemostatic defect caused by HES, and assessed whole blood coagulation by thromboelastometry coagulation analysis (ROTEM, Pentapharm Co., Munich, Germany) in serial in vitro haemodilutions of colloids.
Whole blood was withdrawn from 12 volunteers in a crossover study. Six per cent low-molecular weight HES with a high (HES MW 120 kDa/degree of substitution 0.7) and low (HES MW 130 kDa/0.4) degree of substitution, 4% succinylated gelatin (GEL) or 4% albumin (ALB) was added to citrated venous whole blood samples to make 20, 40, 60 vol.% end-concentrations of each of the solutions. Samples were analyzed by ROTEM.
There was a comparable decrease in maximum clot firmness (MCF) and shear elastic modulus [G = 5000 x MCF/(100-MCF)] by HES 120/0.7 and HES 130/0.4 at 20 and 40 vol.% dilutions. At 60 vol.% dilution HES 120/0.7 decreased less alpha-angle and MCF than HES 130/0.4 (P < 0.05). With moderate dilutions all colloids shortened coagulation time (CT). At 20, 40 and 60 vol.% dilutions MCF and G were more decreased in both HES groups than in the ALB and GEL groups (P < 0.05). Furthermore, at 40 and 60 vol.% dilutions G deteriorated more in the GEL than in the ALB group (P < 0.05).
In vitro the impact of the degree of substitution of HES solution on thromboelastometry coagulation analysis was modest. Haemodilution with gelatin and albumin induced fewer coagulation abnormalities than HES. In addition, the haemodilution with gelatin impaired coagulation more than albumin solution.
羟乙基淀粉(HES)溶液会损害止血机制。HES溶液的取代度(DS)对血栓弹力图描记的影响尚不清楚。因此,我们检验了DS是否对HES引起的止血缺陷有影响这一假设,并通过血栓弹力图凝血分析(ROTEM,德国慕尼黑Pentapharm公司)在胶体的系列体外血液稀释中评估全血凝固情况。
在一项交叉研究中从12名志愿者身上采集全血。将具有高(HES分子量120 kDa/取代度0.7)和低(HES分子量130 kDa/0.4)取代度的6%低分子量HES、4%琥珀酰明胶(GEL)或4%白蛋白(ALB)添加到枸橼酸化静脉全血样本中,制成每种溶液20%、40%、60%体积分数的终浓度。样本通过ROTEM进行分析。
在20%和40%体积分数稀释时,HES 120/0.7和HES 130/0.4使最大血凝块硬度(MCF)和剪切弹性模量[G = 5000×MCF/(100 - MCF)]有类似程度的降低。在60%体积分数稀释时,HES